The effects of a COX-2 inhibitor meloxicam on squamous cell carcinoma of the esophagus in vivo.
about
Surgical quality of care in esophageal malignancies.The role of Pea3 group transcription factors in esophageal squamous cell carcinoma.Combined zoledronic acid and meloxicam reduced bone loss and tumour growth in an orthotopic mouse model of bone-invasive oral squamous cell carcinoma.Blocking autophagy enhances meloxicam lethality to hepatocellular carcinoma by promotion of endoplasmic reticulum stress.A selective cyclooxygenase-2 inhibitor prevents inflammation-related squamous cell carcinogenesis of the forestomach via duodenogastric reflux in rats.
P2860
The effects of a COX-2 inhibitor meloxicam on squamous cell carcinoma of the esophagus in vivo.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
The effects of a COX-2 inhibit ...... noma of the esophagus in vivo.
@en
The effects of a COX-2 inhibit ...... noma of the esophagus in vivo.
@nl
type
label
The effects of a COX-2 inhibit ...... noma of the esophagus in vivo.
@en
The effects of a COX-2 inhibit ...... noma of the esophagus in vivo.
@nl
prefLabel
The effects of a COX-2 inhibit ...... noma of the esophagus in vivo.
@en
The effects of a COX-2 inhibit ...... noma of the esophagus in vivo.
@nl
P2093
P356
P1476
The effects of a COX-2 inhibit ...... noma of the esophagus in vivo.
@en
P2093
Bao-En Shan
Glyn G Jamieson
Gui-Jun Zhu
Jun-Feng Liu
Shao-Wei Zhang
Tie-Cheng Wu
Tie-Nian Zhu
P304
P356
10.1002/IJC.23288
P50
P577
2008-04-01T00:00:00Z